October 17, 2017
This week, RealTalk MS is all about MS research. We often hear about some of the important outcomes of MS research. New drugs, like Ocrevus, are introduced. New information, like the connection between gut bacteria and MS, is published. But how and where does an MS research project get its start? How does it get funded? How much multiple sclerosis research is actively taking place today?
This week, RealTalk MS is all about MS research. We often hear about some of the important outcomes of MS research. New drugs, like Ocrevus, are introduced. New information, like the connection between gut bacteria and MS, is published. But how and where does an MS research project get its start? How does it get funded? How much multiple sclerosis research is actively taking place today?
Jon's guest this week is Dr. Bruce Bebo, Executive Vice President of Research at the National Multiple Sclerosis Society. Since its inception, the National MS Society has invested more than $900 million dollars in MS research. Jon and Bruce discuss the key research priorities that the MS Society has identified, and then take you on a step-by-step “behind the scenes” look at exactly how the National MS Society evaluates and funds MS research.
We'll also be talking about a new law in California that represents a giant leap forward in creating transparency in prescription drug prices. Over the past decade, the cost of prescription drugs for treating MS has risen at a sharply alarming rate. This new law may serve as a blueprint for other states to follow.
And we'll give you a heads-up on an upcoming live webcast from ECTRIMS in Paris (the largest conference in the world dedicated to the understanding and treatment of MS), where you'll be updated by a group of amazing researchers leading breakthrough Progressive MS research.
We've got the news, views, interviews & breakthroughs that are important to you. So…are you ready for RealTalk MS?